Yang et al. (2024) demonstrated that mesenchymal stem cells alleviate inflammation and pyroptosis in diabetic cardiomyopathy by modulating the miRNA-223-3p/NLRP3 signaling pathway, suggesting a potential therapeutic mechanism15. Here, NLRP3 is linked to diabetic cardiomyopathy.